RxDoctor Payments Data

Allison Peklansky, DO

Psychiatry · Peachtree Corners, GANPI 1679830178

Payments from drug & device makers

$1,881in general payments, 2019–2025

Across 108 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$471
  • Takeda Pharmaceuticals U.S.A., Inc.$314
  • Teva Pharmaceuticals USA, Inc.$221
  • Johnson & Johnson$144
  • Otsuka America Pharmaceutical, Inc.$121
  • Sunovion Pharmaceuticals Inc.$120
  • plus $490 from 12 others

What the payments were for

  • Food & beverage$1,85198%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,881 in reported general payments places this provider in the 75th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$49,034
Medicare patients
89
Services billed
456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole32$69,550
SeroquelQuetiapine Fumarate15$14,812
Lurasidone Hcl49$10,628
Aripiprazole55$7,497
BelsomraSuvorexant15$7,132
ConcertaMethylphenidate Hcl12$5,202
Duloxetine Hcl136$4,248
Clozapine12$3,693
Desvenlafaxine Succinate ErDesvenlafaxine Succinate63$3,315
Bupropion XlBupropion Hcl107$2,509
Trazodone Hcl187$2,434
Venlafaxine Hcl ErVenlafaxine Hcl97$2,222
Ramelteon16$2,207
Buspirone Hcl130$2,017
Quetiapine Fumarate80$1,770

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$121$69,55032 claims
MerckBelsomra$14$7,13215 claims
Johnson & JohnsonConcerta$144$5,20212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Peachtree Corners

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →